Profile
| Metric | Value |
|---|---|
| Full Name | Corvus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CRVS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | corvuspharma.com |
| Employees | 31 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $25.10 | |
| Price, 1D Change | -1.65% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | -0.07 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.02 | |
| EPS, 1Y Change | -81.49% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.02 | |
| EPS Estimate | -$0.16 | |
| EPS Est. Change | +84.82% | |
| Revenue | $0.00 | |
| Revenue Estimate | $600.00K | |
| Revenue Est. Change | - | |
| Current Price | $25.10 | |
| Price Target | - | $14.00 |
| Price Tgt. Change | - | -44.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.55 | -$0.56 | -2.33% | |
| -$0.92 | -$1.02 | -10.78% | |
| -$0.16 | N/A | +84.82% | |
| -$0.59 | N/A | +42.73% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $600.00K | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +373.58% | |
| Price, 3Y | +3,037.50% | |
| Market Cap, 1Y | +420.89% | |
| Market Cap, 3Y | +4,933.23% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -81.49% | |
| EPS, 3Y | +1.13% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $25.10 | |
| SMA 200 | $6.07 | |
| SMA 200 vs Price | -75.82% | |
| SMA 50 | $9.22 | |
| SMA 50 vs Price | -63.25% | |
| Beta | -0.07 | |
| ATR | $1.88 | |
| 14-Day RSI | 90.74 | |
| 10-Day Volatility | 820.58% | |
| 1-Year Volatility | 182.60% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.02 | |
| Gross Profit | -$85.00K | |
| - | ||
| Operating Profit | -$27.55M | |
| - | ||
| Net Income | -$62.29M | |
| - | ||
| EBITDA | -$27.46M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.03 | |
| 1.54 | ||
| 1.54 | ||
| - | ||
| - | ||
| 21.90 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 26.12 | ||
| -46.69 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $32.57M | |
| $8.74M | ||
| $68.91M | ||
| $54.41M | ||
| $36.34M | ||
| $35.40M | ||
| Total Debt | $1.12M | |
| $185.00K | ||
| $2.58M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $62.29M | ||
| $27.46M | ||
| $85.00K | ||
| $0.00 | ||
| $85.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$25.42M | ||
| -$27.48M | ||
| $49.03M | ||
| Capex | $0.00 | |
| -$25.42M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Mizuho | → | |
| Oppenheimer | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Oppenheimer | → | |
| Ladenburg Thalmann | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with CRVS
FAQ
What is the ticker symbol for Corvus Pharmaceuticals, Inc.?
The ticker symbol for Corvus Pharmaceuticals, Inc. is NASDAQ:CRVS
Does Corvus Pharmaceuticals, Inc. pay dividends?
No, Corvus Pharmaceuticals, Inc. does not pay dividends
What sector is Corvus Pharmaceuticals, Inc. in?
Corvus Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Corvus Pharmaceuticals, Inc. in?
Corvus Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Corvus Pharmaceuticals, Inc. based in?
Corvus Pharmaceuticals, Inc. is headquartered in United States
When did Corvus Pharmaceuticals, Inc. go public?
Corvus Pharmaceuticals, Inc. initial public offering (IPO) was on March 23, 2016
Is Corvus Pharmaceuticals, Inc. in the S&P 500?
No, Corvus Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Corvus Pharmaceuticals, Inc. in the NASDAQ 100?
No, Corvus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Corvus Pharmaceuticals, Inc. in the Dow Jones?
No, Corvus Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Corvus Pharmaceuticals, Inc. last earnings report?
Corvus Pharmaceuticals, Inc.'s most recent earnings report was on November 4, 2025
When does Corvus Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Corvus Pharmaceuticals, Inc. is March 4, 2026
Data Sources & References
- CRVS Official Website www.corvuspharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1626971/000110465925106259/0001104659-25-106259-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1626971/000155837025003621/0001558370-25-003621-index.htm
- CRVS Profile on Yahoo Finance finance.yahoo.com/quote/CRVS
- CRVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crvs